¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"relative valvular insufficiency"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • relative flatness
    »ó´ëŹÀ½
  • relative frequency
    »ó´ëºóµµ, ºñ±³ºóµµ
  • relative hearing
    »ó´ëÀûû°¨
  • relative humidity
    »ó´ë½Àµµ
  • relative immunity
    »ó´ë¸é¿ª
  • relative leukocytosis
    »ó´ëÀû¹éÇ÷±¸Áõ°¡(Áõ)
  • relative magnetic permeability
    »ó´ëÀÚ±âÅõ°ú·Â
  • relative metabolic rate
    »ó´ë´ë»çÀ²
  • relative motion
    »ó´ë¿îµ¿
  • relative odds
    »ó´ëÀû´ëÀÀºñ
  • relative refractory period
    »ó´ëºÒÀÀ±â
  • relative risk
    »ó´ëÀ§Çèµµ
  • relative risk ratio
    »ó´ëÀ§Çèºñ
  • relative scotoma
    »ó´ë¾ÏÁ¡
  • relative sterility
    »ó´ëÀûºÒÀÓ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • relative risk estimation
    »ó´ëÀ§ÇèµµÃßÁ¤
  • relative flatness
    »ó´ëŹÀ½
  • relative frequency
    ºñ±³ºóµµ
  • haplodistinct relative
    ÀϹè¼öÀÌÁ¾°ü°è
  • haploidentical relative
    ÀϹè¼öµ¿Á¾°ü°è
  • relative hearing
    »ó´ëÀûû°¨
  • relative humidity
    »ó´ë½Àµµ
  • relative immunity
    »ó´ë¸é¿ª
  • relative incompetence
    »ó´ë¼ººÎÀü
  • relative leukocytosis
    ºñ±³¹éÇ÷±¸Áõ°¡Áõ
  • relative motion
    »ó´ë¿îµ¿
  • time dependent relative risk model
    ½Ã°£ÀÇÁ¸»ó´ëÀ§Çè¸ðµ¨
  • relative odds
    »ó´ëÀû´ëÀÀºñ
  • relative magnetic permeability
    »ó´ëÀÚ±âÅõ°ú·Â
  • relative refractory period
    »ó´ëºÒÀÀ±â
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • placental insufficiency
    ŹݺÎÀü(Áõ)(÷ÃÚïÝÕîï(ñø))
  • primary glomerular insufficiency
    ¿ø¹ß(¼º) »ç±¸Ã¼ºÎÀü(¡­ÞêϹô÷ÝÕîï).
  • primary glomerular insufficiency
    ¿ø¹ß(¼º) »ç±¸Ã¼ºÎÀü(ê«Û¡(àõ) ÞêϹô÷ÝÕîï)
  • pulmonary insufficiency
    Æóµ¿¸ÆÆÇ¸·Æó¼âºÎÀü(Áõ)(øËÔÑØæ÷ûدøÍáðÝÕîï(ñø),Æó±â´ÉºÎÀü(øËѦÒöÜôîï)
  • renal failure =r. insufficiency
    ½ÅºÎÀü (ãìÝÕîï).
  • renal failure =r. insufficiency
    ½ÅºÎÀü(ãìÝÕîï)
  • renal insufficiency
    ½Å(±â´É)ºÎÀü(ãìѦÒöÝÕîï).
  • renal insufficiency
    ½Å(±â´É)ºÎÀü(ãìѦÒöÝÕîï)
  • renal insufficiency
    ½ÅºÎÀü
  • haplodistinct relative
    ÀϹè¼öÀÌÁ¾°ü°è<--ģô>
  • haploidentical relative
    ÀϹè¼öµ¿Á¾°ü°è<--ģô>
  • hearing, relative
    »ó´ëÀû û°¨
  • radiation,relative biologic effectiveness(rbe)
    »ó´ëÀû(ºñ±³Àû)»ý¹°ÇÐÀûÈ¿°ú(ßÓÓßîÜ(ÝïÎòîÜßæÚªùÊîÜüùÍý)
  • relative accommodation
    »ó´ëÁ¶Àý(ÝïÎòðàï½).
  • relative acidosis
    »ó´ëÀû »êÁõ(ßÓÓßîÜß«ñø).
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
  • valvular pneumothorax
    ÆÇ»ó±âÈä(÷ûßÒѨýØ)
  • valvular pulmonic stenosis
    ÆÇ¸·¼º Æóµ¿¸ÆÇùÂøÁõ(÷ûدàõøËÔÑØæúõó¸ñø).
  • valvular pulmonic stenosis
    ÆÇ¸·¼º Æóµ¿¸ÆÇùÂøÁõ(÷ûدàõøËÔÑØæúõó¸ñø)
  • valvular regurgitation
    ÆÇ¿ª·ù·®(÷ûæ½êüåÖ).
  • valvular regurgitation
    ÆÇ¿ª·ù·®(÷ûæ½êüåÖ).
  • valvular sinus
    ÆÇ¸·µ¿±¼
  • valvular stenosis
    ÆÇÇùÂø(÷ûúõó¸).
  • valvular stenosis
    ÆÇÇùÂø(÷ûúõó¸)
  • first degree relative
    ÀϵîÄ£(ìéÔõöÑ).
  • haplodistinct relative
    ÀϹè¼öÀÌÁ¾°ü°è<--ģô>
  • haploidentical relative
    ÀϹè¼öµ¿Á¾°ü°è<--ģô>
  • hearing, relative
    »ó´ëÀû û°¨
  • radiation,relative biologic effectiveness(rbe)
    »ó´ëÀû(ºñ±³Àû)»ý¹°ÇÐÀûÈ¿°ú(ßÓÓßîÜ(ÝïÎòîÜßæÚªùÊîÜüùÍý)
  • relative accommodation
    »ó´ëÁ¶Àý(ÝïÎòðàï½).
  • relative acidosis
    »ó´ëÀû »êÁõ(ßÓÓßîÜß«ñø).
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
VHD Valvular Heart Disease
AVD aortic valvular disease; apparent volume of distribution; atrioventricular dissociation; Army Veteri...
AVHD acquired valvular heart disease
AVHS acquired valvular heart syndrome
CVHD chronic valvular heart disease
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 3
MI Mitral insufficiency
PI Pancreatic insufficiency
RI Renal insufficiency
TI Tricuspid insufficiency
VPI Velopharyngeal insufficiency
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • pancreatic insufficiency
    ÃéÀå ±â´É ºÎÀü
    ÃéÀåÀÇ Æ¯È÷ ¿ÜºÐºñ¼º ±â´ÉÀÌ ºÒÃæºÐÇϱ⠶§¹®¿¡ Èí¼ö ºÒ·®¼º ÁõÈıºÀ» ³ªÅ¸³»´Â °æ¿ì¸¦ ¸»ÇÑ´Ù. ü¿Ü ºÐºñ¼±ÀÇ ¿¹ºñ ´É·ÂÀº ±ØÈ÷ Å©°í ÀÌ¿Í °°Àº º´Å¿¡¼­´Â ±¤¹üÀ§ÇÏ°Ô Ãë ½ÇÁúÀÇ È²Æó°¡ Á¸ÀçÇÑ´Ù.
  • pituitary insufficiency
    ³úÇϼöü ±â´É ºÎÀü
  • pulmonary insufficiency
    Æó µ¿¸ÆÆÇ¸· Æó¼â ºÎÀü, Æó µ¿¸ÆÆÇ¸· Æó¼â ºÎÀüÁõ, Æó ±â´É ºÎÀü
  • ventilatory insufficiency
    ȯ±â ºÎÀü
  • vertebral insufficiency
    ôÃß ºÎÀü
  • vertebrobasilar insufficiency
    ôÃß±âÀü Ç÷°üºÎÀü
    ³ë³â¿¡¼­ ÈçÇÑ ÇöÈÆÀÇ ¿øÀÎÀÌ´Ù. ÈçÈ÷ ÀÚ¼¼ º¯È­ ¶Ç´Â ¸ñ ½ÅÀü¿¡ ÀÇÇØ À¯¹ßµÈ´Ù. ôÃß±âÀú°èÀÇ Ç÷·ù °¨¼Ò´Â ºñħ½ÀÀûÀ¸·Î MRÇ÷°ü Á¶¿µ¼úÀ» ÅëÇØ ¾Ë ¼ö ÀÖ´Ù. ÀÓ»óÀû Ä¡·á·Î´Â Ç÷°ü È®ÀåÁ¦, ¾Æ½ºÇǸ°, ±×¸®°í ¿îµ¿¿ä¹ýÀÌ ÀÖ´Ù. ÆíµÎÅëÀÌ ÇöÈÆ ¹ßÀÛÀ» À¯¹ßÇÒ ¼ö ÀÖ´Ù. ÀüÇüÀû µÎÅëÀÇ ÇüŸ¦ ÃëÇÒ °æ¿ì Áø´ÜÀº ºÐ¸íÇÏ´Ù. ±×·¯³ª Ç×»ó ±×·¸Áö´Â ¾Ê´Ù. ¾çÂÊ ÆíµÎÅë°ú Àç¹ß¼º ÇöÈÆÀÇ º´·ÂÀÌ Àִ ȯÀÚ¿¡¼­´Â adrenergic blocking agents¿Í ergotÀÌ ÇÕ´çÇÏ´Ù. ³ú°£¿¡ ³ú½Å°æ ÀÔ±¸ ±âÀúºÎ¸¦ °ø±ÞÇÏ´Â Ç÷°ü°í¸®µéÀº ÀÌ»óÀ» À¯¹ßÇÏ´Â °ÍÀ¸·Î º¸¿©Áø´Ù. ³Î¸® ÀνĵǾî Áö°í ÀÖ´Â ¿¹µéÀº ¾È¸é ÇÑÂÊÀÇ ¶³¸²°ú »ïÂ÷½Å°æÅë
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 3
relative specificity The specificity of a medical screening test as determined by comparison with the same type of test (e.g., specificity of a new serological test relative to specificity of an established serological test).
(05 Mar 2000)
relative value scales Coded listings of physician or other professional services using units that indicate the relative value of the various services they perform. They take into account time, skill, and overhead cost required for each service, but generally do not consider the relative cost-effectiveness. Appropriate conversion factors can be used to translate the abstract units of the relative value scales into dollar fees for each service based on work expended, practice costs, and training costs.
(12 Dec 1998)
relative viscosity The ratio of the viscosity of a solution or dispersion to the viscosity of the solvent or continuous phase.
(05 Mar 2000)
5-year relative survival rate <statistics> The likelihood that a patient will not die from causes associated with his or her cancer for at least 5 years after diagnosis. This is the standard many professionals use when determining someone a survivor of cancer.
(16 Dec 1997)
acute adrenocortical insufficiency Severe adrenocortical insufficiency when an intercurrent illness or trauma causes an increased demand for adrenocortical hormones in a patient with adrenal insufficiency due to disease or use of relatively large amounts of similar hormones as therapy; characterised by nausea, vomiting, hypotension, and frequently hyperthemia, hyponatraemia, hyperkalaemia, and hypoglycaemia; can be fatal if untreated.
Synonym: addisonian crisis, adrenal crisis, Bernard-Sergent syndrome.
(05 Mar 2000)
adrenal gland insufficiency <endocrinology> A condition that results from the inadequate production of adrenal hormones (see Addison's disease).
(27 Sep 1997)
adrenal insufficiency <endocrinology> A condition that results from the inadequate production of adrenal hormones (see Addison's disease).
(27 Sep 1997)
adrenocortical insufficiency Loss, to varying degrees, of adrenocortical function.
Synonym: hypocorticoidism.
(05 Mar 2000)
aortic insufficiency A congenital or acquired heart valve abnormality that results in the abnormal back flow of blood in the aorta, through an incompetent aortic valve and into the left ventricle. Chronic aortic insufficiency leads to enlargement of the left ventricle and pulmonary congestion. If left uncorrected, congestive heart failure will result. Aortic valve replacement is eventually necessary in most cases of significant valvular incompetence.
(27 Sep 1997)
aortic valve insufficiency Backflow of blood from the aorta into the left ventricle, owing to imperfect functioning of the aortic semilunar valve.
(12 Dec 1998)
cardiac insufficiency A condition where there is ineffective pumping of the heart leading to an accumulation of fluid in the lungs. Typical symptoms include shortness of breath with exertion, difficulty breathing when lying flat and leg or ankle swelling. Causes include chronic hypertension, cardiomyopathy and myocardial infarction.
(27 Sep 1997)
pancreatic insufficiency Not enough of the digestive enzymes normally secreted by the pancreas into the intestine. Pancreatic insufficiency is a hallmark of cystic fibrosis.
(12 Dec 1998)
velopharyngeal insufficiency Failure of the soft palate to reach the posterior pharyngeal wall. It may be caused by cleft palate surgery, palatal or pharyngeal abnormalities or injury, or neuromuscular dysfunction of the velopharyngeal sphincter. It causes hypernasality of speech.
(12 Dec 1998)
venous insufficiency <cardiology, surgery> A condition in which the vein do not channel the flow of blood adequately. most often this condition is seen in the veins of the lower extremities.
Symptoms include leg swelling, leg pain and muscle cramps. This condition can predispose to venous thrombosis.
(12 Jan 1998)
parathyroid insufficiency <endocrinology> A term which describes the abnormally low production of parathyroid hormone by the parathyroid glands.
Hypoparathyroidism may be congenital or occur in association with another disorder (autoimmune disease, haemochromatosis).
Common symptoms are those of low blood calcium: muscle spasms, tetany, facial grimacing, laryngeal spasm and seizures.
(11 Jan 1998)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 3
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 3
ÅëÇÕ°Ë»ö ¿Ï·á